Your browser doesn't support javascript.
loading
Gemfibrozil, a lipid-lowering drug, improves hepatorenal damages in a mouse model of aging.
Hakimizadeh, Elham; Tadayon, Saeedeh; Zamanian, Mohammad Yasin; Soltani, Afsaneh; Giménez-Llort, Lydia; Hassanipour, Mahsa; Fatemi, Iman.
Afiliação
  • Hakimizadeh E; Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Tadayon S; Department of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Zamanian MY; Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Soltani A; Department of Physiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Giménez-Llort L; Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Hassanipour M; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Fatemi I; Institut de Neurociències & Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Fundam Clin Pharmacol ; 37(3): 599-605, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36600528

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Genfibrozila Limite: Animals Idioma: En Revista: Fundam Clin Pharmacol Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Genfibrozila Limite: Animals Idioma: En Revista: Fundam Clin Pharmacol Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido